Amedeo's Top 20

Amedeo Smart

Independent Medical Education


13 February 2023

Multidisciplinary Journal Club

  1. Castilla J, Garcia Cenoz M, Abad R, Sanchez-Cambronero L, et al.
    Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
    N Engl J Med 2023;388:427-438.

  1. Abrahami D, Pradhan R, Yin H, Yanofsky R, et al.
    Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study.
    Gut 2023.

  2. Bloem BR, Post E, Hall D.
    An Apple a day to keep the Parkinson's disease doctor away?
    Ann Neurol 2023.

  3. Largent EA, Grill J, O'Brien K, Wolk D, et al.
    Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.
    Neurology 2023.

  4. Novello S, Kowalski DM, Luft A, Gumus M, et al.
    Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
    J Clin Oncol 2023.

  1. Bowman C, Ambrose A, Kanitkar T, Flores K, et al.
    Real world use of dolutegravir two drug regimens.
    AIDS 2023.

  2. Trapani D.
    Adjuvant Chemotherapy in Older Women With Early Breast Cancer.
    J Clin Oncol 2023.

  3. Falini B, Martino G, Lazzi S.
    A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
    Leukemia 2023;37:18-34.

  4. Herbst RS, Wu YL, John T, Grohe C, et al.
    Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.
    J Clin Oncol 2023.

  5. Ferreira GE, Abdel-Shaheed C, Underwood M, Finnerup NB, et al.
    Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews.
    BMJ 2023;380:e072415.

  1. Moon AM, Kim HP, Jiang Y, Lupu G, et al.
    Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy.
    Am J Gastroenterol 2023;118:284-293.

  2. Chaparro M, Acosta D, Rodriguez C, Mesonero F, et al.
    Real-world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness and safety.
    Am J Gastroenterol 2022.

  3. Welzel B, Schmidt R, Johne M, Loscher W, et al.
    Midazolam Prevents the Adverse Outcome of Neonatal Asphyxia.
    Ann Neurol 2023;93:226-243.

  4. May AM, Patel SR, Yamauchi M, Verma TK, et al.
    Moving toward Equitable Care for Sleep Apnea in the United States: Positive Airway Pressure Adherence Thresholds: An Official American Thoracic Society Policy Statement.
    Am J Respir Crit Care Med 2023;207:244-254.

  5. Miyamoto K, Saiki S, Matsumoto H, Suzuki A, et al.
    Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.
    Ann Neurol 2023;93:303-316.

  1. Timmerhuis HC, van Dijk SM, Hollemans RA, Sperna Weiland CJ, et al.
    Short- and long-term outcomes of a disruption and disconnection of the pancreatic duct in necrotizing pancreatitis: a multicenter cohort study in 896 patients : Disrupted pancreatic duct in acute pancreatitis.
    Am J Gastroenterol 2022.

  2. Perl J, Brown EA, Chan CT, Couchoud C, et al.
    Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int 2023.

  3. Kalluri HV, Rosebraugh MR, Misko TP, Ziemann A, et al.
    Phase 1 Evaluation of Elezanumab (Anti-Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants.
    Ann Neurol 2023;93:285-296.

  4. Hill LA, Abulhosn KK, Yin JF, Bamford LP, et al.
    Single center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine.
    AIDS 2022.

  5. Dimopoulos K, Constantine A, Clift P, Condliffe R, et al.
    Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus.
    Circulation 2023;147:425-441.


more..


Privacy Policy